Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

LGBTQ+ rights in Venezuela have suffered under an oppressive government and widespread poverty.

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Over 16,000 individuals living with HIV in Florida might lose access to their essential medications starting March 1 due to a ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

A catastrophic collapse of healthcare services in Malawi a year after US funding cuts is undoing a decade of progress against ...